Clive Morris is the founder of Inivata. Inivata has raised $40M in total funding. Latest round: Series A. Backed by Cambridge Innovation Capital, NeoGenomics.
Clive Morris is a co-founder and former Chief Medical Officer (CMO) of Inivata, a Cambridge-based liquid biopsy company. He was responsible for leading the company's clinical studies and validating its technology platform. Inivata was acquired by NeoGenomics for $415 million in 2021.
Full founder directory · Investor directory · Company funding database · Fundraising library